JP2011516521A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516521A5
JP2011516521A5 JP2011503429A JP2011503429A JP2011516521A5 JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5 JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5
Authority
JP
Japan
Prior art keywords
allergen
dosage form
solid dosage
administration
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011503429A
Other languages
English (en)
Japanese (ja)
Other versions
JP5618981B2 (ja
JP2011516521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/054186 external-priority patent/WO2009124954A1/en
Publication of JP2011516521A publication Critical patent/JP2011516521A/ja
Publication of JP2011516521A5 publication Critical patent/JP2011516521A5/ja
Application granted granted Critical
Publication of JP5618981B2 publication Critical patent/JP5618981B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011503429A 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法 Expired - Fee Related JP5618981B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4440108P 2008-04-11 2008-04-11
US61/044,401 2008-04-11
DKPA200800533 2008-04-11
DKPA200800533 2008-04-11
PCT/EP2009/054186 WO2009124954A1 (en) 2008-04-11 2009-04-08 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014187908A Division JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Publications (3)

Publication Number Publication Date
JP2011516521A JP2011516521A (ja) 2011-05-26
JP2011516521A5 true JP2011516521A5 (enExample) 2012-05-31
JP5618981B2 JP5618981B2 (ja) 2014-11-05

Family

ID=39809974

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011503429A Expired - Fee Related JP5618981B2 (ja) 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Country Status (12)

Country Link
US (2) US9248097B2 (enExample)
EP (1) EP2265285B1 (enExample)
JP (2) JP5618981B2 (enExample)
CN (1) CN102014954A (enExample)
AU (1) AU2009235490B2 (enExample)
BR (1) BRPI0911433A2 (enExample)
CA (1) CA2720455A1 (enExample)
DE (1) DE202008006598U1 (enExample)
EA (1) EA019202B1 (enExample)
ES (1) ES2406391T3 (enExample)
MX (1) MX2010011012A (enExample)
WO (1) WO2009124954A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
CA2813344A1 (en) 2010-10-15 2012-04-19 Alk-Abello A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
WO2012049312A1 (en) * 2010-10-15 2012-04-19 Alk-Abelló A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
JP2012240975A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
JP2012240978A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
AP2014007804A0 (en) 2012-01-16 2014-07-31 Elizabeth Mckenna Compositions and methods for the treatment of hepatic diseases and disorders.
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
JP6306588B2 (ja) 2012-08-21 2018-04-04 サノフィ・バイオテクノロジー Il−4rアンタゴニストを投与することにより喘息を処置又は予防するための方法
WO2014047588A1 (en) 2012-09-21 2014-03-27 Elizabeth Mckenna Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
TWI634900B (zh) 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
EP3110848B1 (en) 2014-02-28 2024-02-14 Regeneron Pharmaceuticals, Inc. Methods for treating skin infection by administering an il-4r antagonist
JP6861630B2 (ja) 2014-11-14 2021-04-21 サノフィ・バイオテクノロジー Il−4rアンタゴニストの投与により鼻ポリープを伴う慢性副鼻腔炎を処置する方法
CN118141914A (zh) 2016-09-01 2024-06-07 瑞泽恩制药公司 用于通过施用il-4r拮抗剂来预防或治疗变态反应的方法
US10485844B2 (en) 2016-09-22 2019-11-26 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
TWI857389B (zh) 2016-12-01 2024-10-01 美商再生元醫藥公司 治療發炎症狀的方法
US11053309B2 (en) 2017-08-04 2021-07-06 Regeneron Pharmaceuticals, Inc. Methods for treating active eosinophilic esophagitis
EP4344706A3 (en) 2017-10-30 2024-05-22 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
MA52624A (fr) 2018-05-13 2021-03-24 Regeneron Pharma Méthodes de traitement de la dermatite atopique par administration d'un inhibiteur de l'il-4r
WO2020191346A1 (en) 2019-03-21 2020-09-24 Regeneron Pharmaceuticals, Inc. Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy
EP3999114A1 (en) 2019-07-16 2022-05-25 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
SG11202113310UA (en) 2019-08-05 2021-12-30 Regeneron Pharma Methods for treating atopic dermatitis by administering an il-4r antagonist
EP4010001A1 (en) 2019-08-05 2022-06-15 Regeneron Pharmaceuticals, Inc. Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist
EP4513185A1 (en) * 2023-08-22 2025-02-26 Luxembourg Institute of Health (LIH) Early response biomarkers for allergen immunotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK137992D0 (da) 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0959179A (ja) * 1995-08-28 1997-03-04 Japan Tobacco Inc スギ花粉症予防性を有する口腔衛生剤
DE69939584D1 (de) 1998-03-16 2008-10-30 Alk Abello As Mutiertes rekombinantes allergen
FR2778244B1 (fr) 1998-04-30 2000-07-13 Univ Joseph Fourier Procede d'excitation d'une cavite optique pour la detection de gaz a l'etat de traces
HUP0302601A3 (en) 2000-11-16 2010-01-28 Alk Abello As Mutant allergens
WO2003096869A2 (en) 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
CA2554337A1 (en) 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
BRPI0508078A (pt) * 2004-02-26 2007-07-17 Alk Abello As método para avaliar o potencial terapêutico de uma vacina para administração mucosa
US20060115499A1 (en) 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
PT1812059E (pt) 2004-11-10 2010-07-26 Alk Abelle As MéTODO DE TRATAMENTO PREVENTIVO DA ALERGIA POR ADMINISTRAÆO POR VIA MUCOSAL DE UMA VACINA PARA A ALERGIA
DE602005021388D1 (de) 2004-11-10 2010-07-01 Alk Abello As Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute
CN101098711A (zh) * 2005-01-07 2008-01-02 阿尔克-阿贝洛有限公司 通过口粘膜施用变态反应疫苗预防性治疗变态反应的方法
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
US20090155351A1 (en) 2005-10-04 2009-06-18 Alk-Abello A/S Solid Vaccine Formulation
US20090297564A1 (en) 2005-11-04 2009-12-03 Domingo Barber Hernandez Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration
DE202007004567U1 (de) 2007-03-28 2007-10-11 Alk-Abelló A/S Verwendung einer adjuvierten Allergievakzinformulierung zur parenteralen Verabreichung
WO2008116936A1 (en) * 2007-03-28 2008-10-02 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Similar Documents

Publication Publication Date Title
JP2011516521A5 (enExample)
US20060062835A1 (en) Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
JP2010132695A5 (enExample)
NZ606548A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
WO2009020561A3 (en) Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid
US20160250168A1 (en) Esters of short chains fatty acids for use in the treatment of immunogenic disorders
MX2010013567A (es) Biopolimeros marinos antialergicos.
CN100512813C (zh) 用于呼吸道疾病治疗的抗胆碱能药和4型磷酸二酯酶抑制剂的组合
JP2019514990A5 (enExample)
JP2013523628A5 (enExample)
JP2007238598A5 (enExample)
WO2010003472A3 (de) Lutschzusammensetzung zur behandlung von entzündlichen erkrankungen des mund- und rachenraums
L Hon et al. Recent patents of complementary and alternative medicine for allergic rhinitis
TW201023869A (en) Antitussive agent and manufacture thereof
JP2013520448A5 (enExample)
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
JP2012508772A5 (enExample)
JP2009539916A5 (enExample)
CN116459295A (zh) 一种肺炎清化方及其应用
Patil et al. Ethno-pharmacological review of a herbal drug: Anogeissus latifolia
CN103169769A (zh) 一种丁香甘草粉
CN117159661A (zh) 一种中药组合物及其制剂和应用
CN1537620A (zh) 治疗口腔粘膜疾病的中药缓释口腔粘附片及其制备方法
JP2007506768A5 (enExample)